A Trail of CDK4 / 6 Inhibitor and MEK Inhibitor in the Treatment of Metastatic Digestive System Tumors
Clinical trial NCT04615312 · UNKNOWN
Trial details
- NCT number
- NCT04615312
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-14
- Primary completion
- 2021-08-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.